AbbVie (ABBV) Stock Forecast & Price Target - TipRanks

The average price target for AbbVie is $199.57. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $218.00 …

CouponFollow Extension

$199.57
OFF

AbbVie (ABBV) Stock Forecast & Price Target - TipRanks

1 week from now

The average price target for AbbVie is $199.57. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $218.00 …

tipranks.com

$210
OFF

AbbVie Price Target Raised To $210 From $195 At BofA - TipRanks

1 week from now

BofA analyst Charlie Yang raised the firm’s price target on AbbVie to $210 from $195 and keeps a Neutral rating on the shares after the company reported “solid” Q3 results and raised 2024 …

tipranks.com

$203.89
OFF

AbbVie (ABBV) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago · According to the 21 analysts' twelve-month price targets for AbbVie, the average price target is $203.89. The highest price target for ABBV is $225.00, while the lowest price …

marketbeat.com

$215
OFF

AbbVie Price Target Raised To $215 From $170 At Citi - Nasdaq

1 week from now

Oct 25, 2024 · Citi raised the firm’s price target on AbbVie (ABBV) to $215 from $170 and keeps a Buy rating on the shares following a transfer of analyst coverage. The firm says that while …

nasdaq.com

$215
OFF

AbbVie Price Target Lowered To $215 From $226 At Citi - Nasdaq

1 week from now

6 days ago · Citi analyst Geoff Meacham lowered the firm’s price target on AbbVie (ABBV) to $215 from $226 and keeps a Buy rating on the shares. The firm says the pivotal Phase 2 data …

nasdaq.com

$205
OFF

Wolfe Starts AbbVie At Outperform, Says Valuation An ... - Nasdaq

1 week from now

3 days ago · Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded "quite confident" on immuno …

nasdaq.com

$221
OFF

AbbVie Price Target Raised To $221 From $212 At Guggenheim

1 week from now

Nov 6, 2024 · Guggenheim analyst Vamil Divan raised the firm’s price target on AbbVie to $221 from $212 and keeps a Buy rating on the shares. The firm is updating its model following the …

tipranks.com

$200
OFF

JPMorgan Trims AbbVie Target, Removes From Analyst Focus List

1 week from now

5 days ago · JPMorgan lowered the firm’s price target on AbbVie (ABBV) to $200 from $210 and keeps an Overweight rating on the shares. While the emracl...

businessinsider.com

$200
OFF

AbbVie Price Target Raised To $200 From $195 At UBS - Nasdaq

1 week from now

Oct 31, 2024 · UBS raised the firm’s price target on AbbVie (ABBV) to $200 from $195 and keeps a Neutral rating on the shares. AbbVie reported another impressive quarter and the focus now …

nasdaq.com

$208
OFF

AbbVie Price Target Lowered To $208 From $228 At BMO Capital

1 week from now

6 days ago · BMO Capital analyst Evan Seigerman lowered the firm’s price target on AbbVie (ABBV) to $208 from $228 and keeps an Outperform rating on the shares. The firm is citing …

nasdaq.com

$60
OFF

Bristol Myers Price Target Raised To $60 From $55 At Citi

1 week from now

6 days ago · Citi raised the firm’s price target on Bristol Myers to $60 from $55 and keeps a Neutral rating on the shares. The firm says the pivotal Phase 2 data for AbbVie’s (ABBV) …

nasdaq.com

$224
OFF

AbbVie Price Target Lowered To $224 From $231 At Morgan Stanley …

1 week from now

Morgan Stanley lowered the firm’s price target on AbbVie to $224 from $231 and keeps an Overweight rating on the shares following the “surprising” negative emraclidine Phase 2 …

tipranks.com

$200
OFF

AbbVie Price Target Raised To $200 From $195 At UBS - TipRanks

1 week from now

UBS raised the firm’s price target on AbbVie (ABBV) to $200 from $195 and keeps a Neutral rating on the shares. ... Get real-time notifications on news & analysis, curated for your stock …

tipranks.com